Artivion (AORT) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Artivion · Health Care · ref. ETF XLV · 50 calls · price $26.67
What the company does: Artivion Inc. is a global company that develops, produces, and supplies medical devices and implantable human tissues.
📈 Artivion (AORT) stock price
$26.67-39.1% over range
Aug 28, 25low $20.1 · high $47.63Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 4 analysts
📊 JPI status : Artivion is no longer in our current JPI rankings, but appeared in the past (2020) — its upside may be behind it. See the stocks picked in 2020 →
🎯 AORT price target & analyst consensus — price $26.67
The price target · all analysts combined (4 targets)
Highest target · 1 firm of 4$48+80.0%
Median target · of 4 targets$43+61.2%
Lowest target · 1 firm of 4$40+50.0%
Current price$26.67
Where these 4 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
4100%
$40 ↔ $48
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 4 ratings (last 6 months)
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 AORT price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on AORT most reliable
Their real reliability on AORT, firm by firm: who was right, who was wrong.
→ See their reliability on AORTAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Artivion? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
🏛️ Which US Congress members hold Artivion (AORT)?
1 Congress member has disclosed AORT buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Josh Gottheimer 1× · 56%
✅ Historical analyst reliability on AORT
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Oppenheimer ↗ | 75% | +29.6% | 4 |
| JMP Securities | 75% | +24.9% | 4 |
| Stifel ↗ | 71% | +24.9% | 7 |
| Lake Street | 67% | +16.8% | 3 |
| Needham ↗ | 65% | +18.9% | 26 |
| Canaccord Genuity ↗ | 33% | -14.1% | 3 |
📊 What $1,000 invested in Artivion would be worth › open the full page
In short — $1,000 invested in Artivion 10 years ago would be worth $2,146 today, i.e. +8%/yr on average. Best year: 2016 (+78%), worst: 2022 (-40%). Price performance, excluding dividends.
If I'd invested $1,000 in Artivion
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $809 | -19% |
| 3 years ago | $1,908 | +91% |
| 5 years ago | $980 | -2% |
Return by year (Artivion)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -49% | $507 (-49%) |
| 2025 | +60% | $809 (-19%) |
| 2024 | +60% | $1,294 (+29%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Artivion
Loading news…
📋 All analyst calls on AORT
Filtered on — · ✕ show all
Canaccord Genuity ↗
Aug 18, 26
▲ Buy · 🎯$40
Price at call : $28.82 — upside +39%
Today : $26.67 — upside +50%
🎯 on AORT : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Aug 18, 27
matures : Aug 18, 27
▲ Buy · 🎯$44
Price at call : $25.37 — upside +73%
Today : $26.67 — upside +65%
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jul 20, 27
matures : Jul 20, 27
Canaccord Genuity ↗
Jun 16, 26
▲ Buy · 🎯$36
Price at call : $21.2 — upside +70%
Today : $26.67 — upside +35%
🎯 on AORT : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Jun 16, 27
matures : Jun 16, 27
Citizens
May 8, 26
▲ Market Outperform · 🎯$48
Price at call : $23.81 — upside +102%
Today : $26.67 — upside +80%
🎯 on AORT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Buy · 🎯$44
Price at call : $25.41 — upside +73%
Today : $26.67 — upside +65%
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
Ladenburg Thalmann ↗
Apr 10, 26
▲ Buy · 🎯$42
Price at call : $37.63 — upside +12%
Today : $26.67 — upside +57%
🎯 on AORT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Apr 10, 27
matures : Apr 10, 27
▲ Buy · 🎯$58
Price at call : $36.06 — upside +61%
Today : $26.67 — upside +117%
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Apr 7, 27
matures : Apr 7, 27
Canaccord Genuity ↗
Feb 13, 26
▲ Buy · 🎯$48
Price at call : $36.5 — upside +32%
Today : $26.67 — upside +80%
🎯 on AORT : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Feb 13, 27
matures : Feb 13, 27
See the other 42 calls, newest to oldest
▲ Buy · 🎯$58
Price at call : $41.63 — upside +39%
Today : $26.67 — upside +117%
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Canaccord Genuity ↗
Nov 7, 25
▲ Buy · 🎯$51
Price at call : $44.98 — upside +13%
Today : $26.67 — upside +91%
🎯 on AORT : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Citizens
Nov 7, 25
▲ Market Outperform · 🎯$53
Price at call : $44.87 — upside +18%
Today : $26.67 — upside +99%
🎯 on AORT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$58
Price at call : $44.87 — upside +29%
Today : $26.67 — upside +117%
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
JMP Securities
Oct 10, 25
▲ Market Outperform · 🎯$47
Price at call : $40.2 — upside +17%
Today : $26.67 — upside +76%
🎯 on AORT : 75% (4 calls matureds) · 📊 unranked overall
in progress (365j)
matures : Oct 10, 26
matures : Oct 10, 26
▲ Buy · 🎯$46
Price at call : $42.34 — upside +9%
Today : $26.67 — upside +72%
🎯 on AORT : 83% (6 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Sep 29, 26
matures : Sep 29, 26
Canaccord Genuity ↗
Sep 29, 25
▲ Buy · 🎯$50
Price at call : $42.04 — upside +19%
Today : $26.67 — upside +87%
🎯 on AORT : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Sep 29, 26
matures : Sep 29, 26
▲ Buy · 🎯$50
Price at call : $44.83 — upside +12%
Today : $26.67 — upside +87%
Expected +12% · Actual -40% · Reason (≥ +15%) : ✗ No
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-40.0%
stock -40% · XLV +26%
matured Aug 22, 26
Ladenburg Thalmann ↗
Aug 13, 25
■ Neutral neutral · not a buy · 🎯$38.8
Price at call : $42.95 — gap to target -10%
Today : $26.67 — gap to target +45%
🎯 on AORT : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 13, 26
matures : Aug 13, 26
Canaccord Genuity ↗
Aug 8, 25
▲ Buy · 🎯$41
Price at call : $42.96 — upside -5%
Today : $26.67 — upside +54%
Expected -5% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on AORT : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-38.8%
stock -39% · XLV +29%
matured Aug 8, 26
JMP Securities
Aug 8, 25
▲ Market Outperform · 🎯$42
Price at call : $42.96 — upside -2%
Today : $26.67 — upside +57%
Expected -2% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on AORT : 75% (4 calls matureds) · 📊 unranked overall
-38.8%
stock -39% · XLV +29%
matured Aug 8, 26
▲ Buy · 🎯$40
Price at call : $42.96 — upside -7%
Today : $26.67 — upside +50%
Expected -7% · Actual -39% · Reason (≥ +15%) : ✗ No
🎯 on AORT : 83% (6 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
-38.8%
stock -39% · XLV +29%
matured Aug 8, 26
▲ Buy · 🎯$45
Price at call : $40.95 — upside +10%
Today : $26.67 — upside +69%
Expected +10% · Actual -36% · Reason (≥ +15%) : ✗ No
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-35.8%
stock -36% · XLV +29%
matured Aug 8, 26
Canaccord Genuity ↗
Jun 17, 25
▲ Buy · 🎯$35
Price at call : $29.77 — upside +18%
Today : $26.67 — upside +31%
Expected +18% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on AORT : 0% (2 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-28.8%
stock -29% · XLV +13%
matured Jun 17, 26
JMP Securities
May 6, 25
▲ Market Outperform · 🎯$33
Price at call : $28.38 — upside +16%
Today : $26.67 — upside +24%
Expected +16% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 75% (4 calls matureds) · 📊 unranked overall
+24.8%
stock +25% · XLV +7%
matured May 6, 26
▲ Buy · 🎯$32
Price at call : $27.42 — upside +17%
Today : $26.67 — upside +20%
Expected +17% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+26.7%
stock +27% · XLV +8%
matured May 6, 26
Citizens Capital Markets
Feb 25, 25
▲ Market Outperform · 🎯$33
Price at call : $25.42 — upside +30%
Today : $26.67 — upside +24%
Expected +30% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 100% (1 call matured) · 📊 unranked overall
+49.8%
stock +50% · XLV +6%
matured Feb 25, 26
▲ Buy · 🎯$30
Price at call : $25.56 — upside +17%
Today : $26.67 — upside +12%
Expected +17% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 83% (6 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
+40.0%
stock +40% · XLV +6%
matured Feb 25, 26
▲ Buy · 🎯$32
Price at call : $25.56 — upside +25%
Today : $26.67 — upside +20%
Expected +25% · Actual +40% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+40.0%
stock +40% · XLV +6%
matured Feb 25, 26
▲ Buy · 🎯$34
Price at call : $31.22 — upside +9%
Today : $26.67 — upside +27%
Expected +9% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+29.5%
stock +29% · XLV +6%
matured Jan 28, 26
JMP Securities
Dec 10, 24
▲ Market Outperform · 🎯$33
Price at call : $29.92 — upside +10%
Today : $26.67 — upside +24%
Expected +10% · Actual +52% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 75% (4 calls matureds) · 📊 unranked overall
+52.0%
stock +52% · XLV +8%
matured Dec 10, 25
▲ Buy · 🎯$34
Price at call : $29.83 — upside +14%
Today : $26.67 — upside +27%
Expected +14% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+48.2%
stock +48% · XLV +6%
matured Dec 9, 25
Oppenheimer ↗
Nov 8, 24
▲ Outperform · 🎯$32
Price at call : $28.87 — upside +11%
Today : $26.67 — upside +20%
Expected +11% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 100% (2 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+55.8%
stock +56% · XLV -1%
matured Nov 8, 25
JMP Securities
Oct 23, 24
▲ Market Outperform · 🎯$33
Price at call : $26.86 — upside +23%
Today : $26.67 — upside +24%
Expected +23% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 75% (4 calls matureds) · 📊 unranked overall
+61.6%
stock +62% · XLV -3%
matured Oct 23, 25
▲ Buy · 🎯$30
Price at call : $26.85 — upside +12%
Today : $26.67 — upside +12%
Expected +12% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+56.6%
stock +57% · XLV -11%
matured Sep 27, 25
▲ Buy · 🎯$30
Price at call : $25.38 — upside +18%
Today : $26.67 — upside +12%
Expected +18% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 83% (6 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
+56.7%
stock +57% · XLV -13%
matured Sep 13, 25
▲ Buy · 🎯$30
Price at call : $25.13 — upside +19%
Today : $26.67 — upside +12%
Expected +19% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+71.0%
stock +71% · XLV -13%
matured Aug 9, 25
Oppenheimer ↗
Aug 9, 24
▲ Outperform · 🎯$30
Price at call : $25.13 — upside +19%
Today : $26.67 — upside +12%
Expected +19% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 100% (2 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+71.0%
stock +71% · XLV -13%
matured Aug 9, 25
▲ Buy · 🎯$28
Price at call : $24.85 — upside +13%
Today : $26.67 — upside +5%
Expected +13% · Actual +73% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 83% (6 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
+72.9%
stock +73% · XLV -13%
matured Aug 9, 25
Lake Street
Jul 2, 24
▲ Buy · 🎯$30
Price at call : $25.85 — upside +16%
Today : $26.67 — upside +12%
Expected +16% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 100% (1 call matured) · 📊 on Health : 61.5% · +24.8% (26 calls)
+18.8%
stock +19% · XLV -5%
matured Jul 2, 25
▲ Buy · 🎯$25
Price at call : $23.77 — upside +5%
Today : $26.67 — upside -6%
Expected +5% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 83% (6 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
+19.4%
stock +19% · XLV -5%
matured May 7, 25
▲ Buy · 🎯$30
Price at call : $23.77 — upside +26%
Today : $26.67 — upside +12%
Expected +26% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+19.4%
stock +19% · XLV -5%
matured May 7, 25
▲ Buy · 🎯$25
Price at call : $21.64 — upside +16%
Today : $26.67 — upside -6%
Expected +16% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+10.7%
stock +11% · XLV -3%
matured Apr 8, 25
▲ Buy · 🎯$22
Price at call : $18.7 — upside +18%
Today : $26.67 — upside -18%
Expected +18% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 83% (6 calls matureds) · 📊 on Health : 44.8% · +6.7% (96 calls)
+59.7%
stock +60% · XLV -0%
matured Feb 15, 25
▲ Buy · 🎯$25
Price at call : $18.81 — upside +33%
Today : $26.67 — upside -6%
Expected +33% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+58.8%
stock +59% · XLV -1%
matured Feb 15, 25
▲ Buy · 🎯$22
Price at call : $18 — upside +22%
Today : $26.67 — upside -18%
Expected +22% · Actual +65% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+64.8%
stock +65% · XLV +9%
matured Dec 6, 24
▲ Buy · 🎯$22
Price at call : $14.23 — upside +55%
Today : $26.67 — upside -18%
Expected +55% · Actual +93% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+93.0%
stock +93% · XLV +15%
matured Nov 2, 24
▲ Buy · 🎯$26
Price at call : $16.52 — upside +57%
Today : $26.67 — upside -3%
Expected +57% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+51.3%
stock +51% · XLV +11%
matured Aug 3, 24
Morgan Stanley ↗
May 8, 23
■ Equal-Weight neutral · not a buy · 🎯$15
Price at call : $14.61 — gap to target +3%
Today : $26.67 — gap to target -44%
🎯 on AORT : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : May 7, 24
matures : May 7, 24
▲ Buy · 🎯$26
Price at call : $15.19 — upside +71%
Today : $26.67 — upside -3%
Expected +71% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+38.7%
stock +39% · XLV +6%
matured May 4, 24
▲ Buy · 🎯$23
Price at call : $13.96 — upside +65%
Today : $26.67 — upside -14%
Expected +65% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on AORT : 88% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+34.0%
stock +34% · XLV +10%
matured Feb 17, 24
Frequently asked questions
Should I buy Artivion stock?
This isn't buy advice. For Artivion, the analyst consensus is "Buy", with an average price target of $43.00 (+61% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 75% of the time (4 calls tracked on Artivion). We show the numbers — you decide.
Is it too late to buy Artivion? How high can it go?
The most bullish analyst target on Artivion is $48.00 (+80% above today's price); the average is $43.00. That's the upside they see. Check how reliable those analysts have actually been on Artivion on our site before trusting it.
Is Artivion still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 6 analysts have a real record on Artivion, the best hitting 75% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Will Artivion stock recover (go back up)?
It's down from its high. We answer with the numbers — the analysts' 12-month target and what happened after its past drops: will AORT stock recover (go back up)?
What has Artivion's past performance been?
Historical returns and a "how much if I had invested" calculator: AORT performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX